These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31543943)

  • 1. Frequency of chemoradiotherapy-induced mucositis and related risk factors in patients with the head-and-neck cancers: A survey in the North of Iran.
    Saedi HS; Gerami H; Soltanipour S; Habibi AF; Mirhosseyni M; Montazeri S; Nemati S
    Dent Res J (Isfahan); 2019; 16(5):354-359. PubMed ID: 31543943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
    Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
    Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
    Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of rebamipide mouthwash therapy for radiotherapy and chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis.
    Akagi S; Fujiwara T; Nishida M; Okuda A; Nagao Y; Okuda T; Tokuda H; Takayanagi K
    J Pharm Health Care Sci; 2019; 5():16. PubMed ID: 31367460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
    Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
    Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
    Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
    Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
    Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
    Lambrecht M; Mercier C; Geussens Y; Nuyts S
    Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients.
    Doi H; Fujiwara M; Suzuki H; Niwa Y; Nakayama M; Shikata T; Odawara S; Takada Y; Kimura T; Kamikonya N; Hirota S
    Mol Clin Oncol; 2015 Mar; 3(2):381-386. PubMed ID: 25798271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.
    Cohen EE; Ahmed O; Kocherginsky M; Shustakova G; Kistner-Griffin E; Salama JK; Yefremenko V; Novosad V
    Oral Oncol; 2013 Oct; 49(10):1025-31. PubMed ID: 23988569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
    Zhu W; Mei H; Jia L; Zhao H; Li X; Meng X; Zhao X; Xing L; Yu J
    Invest New Drugs; 2020 Aug; 38(4):1129-1136. PubMed ID: 31701429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
    Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
    Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Mucositis Among Head and Neck Cancer Patients Receiving Three-Dimensional (3D) Radiotherapy.
    Laique T; Shabbir A; Bilal Ahmadani MA; Yaseen MS; Ahmad A; Malik J
    Cureus; 2020 Jul; 12(7):e9089. PubMed ID: 32789038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.